Taysha Gene Therapies, Inc. - Common Stock, par value $0.00001 per share (TSHA)

CUSIP: 877619106

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / Common Stock, par value $0.00001 per share
Shares outstanding
275,000,000
Total 13F shares
17,015,055
Share change
-1,491,525
Total reported value
$110,894,239
Put/Call ratio
151%
Price per share
$6.52
Number of holders
70
Value change
-$16,224,000
Number of buys
41
Number of sells
23

Quarterly Holders Quick Answers

What is CUSIP 877619106?
CUSIP 877619106 identifies TSHA - Taysha Gene Therapies, Inc. - Common Stock, par value $0.00001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Taysha Gene Therapies, Inc. - Common Stock, par value $0.00001 per share (TSHA) as of Q1 2022

As of 31 Mar 2022, Taysha Gene Therapies, Inc. - Common Stock, par value $0.00001 per share (TSHA) was held by 70 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 17,015,055 shares. The largest 10 holders included FMR LLC, BlackRock Inc., Nantahala Capital Management, LLC, FRANKLIN RESOURCES INC, Artal Group S.A., VANGUARD GROUP INC, Sands Capital Ventures, LLC, TimesSquare Capital Management, LLC, Alphabet Inc., and TYBOURNE CAPITAL MANAGEMENT (HK) LTD. This page lists 70 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.